News | October 19, 2009

ASTRO, Gilda's Club Partner to Raise Cancer Survivorship Awareness

October 19, 2009 - The American Society for Radiation Oncology (ASTRO) is partnering with Gilda's Club Chicago to raise awareness of cancer survivorship issues, as part of an initiative to give back to the communities in the cities visited during its annual scientific meetings.

Gilda's Club Chicago will work with ASTRO by participating in the Survivor Circle exhibit at ASTRO's 51st Annual Meeting, scheduled for November 1-5, 2009, at McCormick Place West in Chicago, Ill. The Survivor Circle was created to recognize those living with a diagnosis of cancer. This year, it will focus on the programs offered by Chicago-area cancer organizations helping patients and their families cope with this disease. Within the Survivor Circle, there is a place for attendees to learn more about this Gilda's Club. Gilda's Club received this opportunity, along with a $10,000 grant, through the Survivor Circle Grant Program. They were one of two groups chosen from 10 applications received this year.

"We are excited to work with such a well-established, nationally recognized organization," Tim R. Williams, president of ASTRO said. "Our patients and their families rely on the programs offered by groups like Gilda's Club Chicago and their programs are fully deserving of this grant and the opportunity to educate our members about the work they do to assist those living with cancer."

"We are honored to be selected by ASTRO to receive this grant and to be showcased at their exciting 51st Annual Meeting," LauraJane Hyde, CEO of Gilda's Club Chicago noted. "To be able to connect their global leadership with the work we are doing in Chicago to build welcoming communities for those affected by cancer is a great partnership."

For more information: www.astro.org

Related Content

What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...
Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case
News | Treatment Planning | March 08, 2019
Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the combination of RaySearch's...
Videos | Proton Therapy | March 01, 2019
ITN Associate Editor Jeff Zagoudis speaks with Mark Pankuch, Ph.D., director of physics and dosimetry at the...
Videos | Proton Therapy | February 28, 2019
ITN Associate Editor Jeff Zagoudis speaks with ...
360_NW_Proton_Center_Gantry_Room_Back_THUMBNAIL
360 Photos | 360 View Photos | February 28, 2019
This is a 360 photo view behind the gantry room at the ...
360_NW_Proton_Center_Inclined_Room_THUMBNAIL
360 Photos | 360 View Photos | February 28, 2019
This is a 360 view of Treatment Room 3 (of 4) at the N...
NW Proton Center Gantry Room Front
360 Photos | 360 View Photos | February 27, 2019
This is a 360 photo view inside the gantry room at the...
While surgery is still the gold standard for lung cancer treatment, radiation therapy can offer a less invasive approach with quicker recovery times

While surgery is still the gold standard for lung cancer treatment, radiation therapy can offer a less invasive approach with quicker recovery times.

Feature | Lung Cancer | February 27, 2019 | By Jeff Zagoudis
Lung cancer is the second most common cancer for both men and women in the United States,...
Videos | Proton Therapy | February 26, 2019
ITN Associate Editor Jeff Zagoudis speaks with ...
Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

News | Radiology Business | February 22, 2019
Imaging Technology News has been recognized with three award nominations from the Jesse H.